UBS Group’s Imago BioSciences, Inc. Common stock IMGO Stock Holding History

UBS Group’s Portfolio IMGO Stock Details IMGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-186,545	Closed	-$6.71M	–	11516
2022 Q4	$6.71M	Buy	186,545 +185,064	+12,496%	+$4.63M	﹤0.01%	2224
2022 Q3	$22K	Buy	+1,481	New	+$24K	﹤0.01%	7298
2022 Q2	–	Sell	-1,288	Closed	-$25K	–	11475
2022 Q1	$25K	Sell	1,288 -3,281	-72%	-$68.1K	﹤0.01%	7219
2021 Q4	$108K	Buy	4,569 +3,640	+392%	+$84.3K	﹤0.01%	6252
2021 Q3	$19K	Buy	+929	New	+$19.9K	﹤0.01%	7251

UBS Group's IMGO Position: Q1 2023 in Review

UBS Group sold out of Imago BioSciences, Inc. Common stock (IMGO) in Q1 2023, closing a stake of 186,545 shares — an estimated $6.71M sold.

UBS Group first reported a position in IMGO in Q3 2021 and held it in 5 quarters. The position peaked at $6.71M in Q4 2022. 0 funds tracked by Wall St. Rank hold IMGO as of Q1 2023.

UBS Group reported no remaining Imago BioSciences, Inc. Common stock position as of Q1 2023 after selling out during the quarter.
UBS Group sold 186,545 Imago BioSciences, Inc. Common stock shares in Q1 2023, an estimated $6.71M.
UBS Group first reported a position in Imago BioSciences, Inc. Common stock in Q3 2021 and held it in 5 quarters.
UBS Group's Imago BioSciences, Inc. Common stock position peaked at $6.71M in Q4 2022.
0 funds tracked by Wall St. Rank held Imago BioSciences, Inc. Common stock as of Q1 2023.

Based on UBS Group's 13F filing for Q1 2023, filed 12 May 2023.